{
    "id": 29439,
    "fullName": "NRG1 fusion",
    "impact": "fusion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "NRG1 fusion indicates a fusion of the NRG1 gene, but the fusion partner is unknown.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 3084,
        "geneSymbol": "NRG1",
        "terms": [
            "NRG1",
            "ARIA",
            "GGF",
            "GGF2",
            "HGL",
            "HRG",
            "HRG1",
            "HRGA",
            "MST131",
            "MSTP131",
            "NDF",
            "NRG1-IT2",
            "SMDF"
        ]
    },
    "variant": "fusion",
    "createDate": "02/21/2019",
    "updateDate": "02/21/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15908,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study,\u00a0a patient with KRAS wild-type pancreatic ductal adenocarcinoma\u00a0harboring\u00a0a SARAF-NRG1-CDH6 fusion had a partial remission of liver metastases when treated with combined\u00a0Tarceva (erlotinib) and\u00a0Perjeta (pertuzumab), but disease progression was observed after three months (PMID: 29802158).",
            "molecularProfile": {
                "id": 31464,
                "profileName": "NRG1 fusion KRAS wild-type"
            },
            "therapy": {
                "id": 7802,
                "therapyName": "Erlotinib + Pertuzumab",
                "synonyms": null
            },
            "indication": {
                "id": 3498,
                "name": "pancreatic ductal adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 13943,
                    "pubMedId": 29802158,
                    "title": "NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29802158"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31463,
            "profileName": "NRG1 fusion",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31464,
            "profileName": "NRG1 fusion KRAS wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}